Hematocrit Reduction From Therapeutic Phlebotomy in Polycythemia Vera
Therapeutic phlebotomy in polycythemia vera is used to lower hematocrit to a goal of <45% (with some protocols using <42% for women). [1] The amount of hematocrit reduction per phlebotomy session varies by baseline hematocrit and circulating red cell mass. [1]
Expected Magnitude of Hematocrit Fall Per Donation Session
A cross-sectional study of polycythemia patients reported an average hematocrit fall of 3.6 percentage points after a single therapeutic phlebotomy session of approximately 350 mL. [2] In the same report, the average hemoglobin fall was 1.2 g/dL after one session of approximately 350 mL. [2]
Key Practical Interpretation for Polycythemia Vera
A “blood donation” volume used for therapeutic phlebotomy (commonly ~350–450 mL in clinical practice) is directionally associated with a short-term hematocrit reduction on the order of a few percentage points per session, rather than a fixed percentage reduction. [1] [2] Targeted phlebotomy is then repeated until the hematocrit goal (<45%) is achieved. [1]
Targets and Monitoring Goals
The clinical monitoring goal after repeated phlebotomy is hematocrit control to <45%. [1] If hematocrit remains above target, additional phlebotomy sessions are indicated for hematocrit control. [1]